Tumor-derived exosomes and microvesicles in head and neck cancer: Implications for tumor biology and biomarker discovery

Proteomics

Volumn 13, Issue 10-11, 2013, Pages 1608-1623

  Principe, Simona ^a   Hui, Angela Bik Yu ^a   Bruce, Jeff ^b   Sinha, Ankit ^b   Liu, Fei Fei ^a,b   Kislinger, Thomas ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biomedicine; Cancer; Exosome; MiRNA

Indexed keywords

BIOLOGICAL MARKER; DNA; ECALECTIN; ESCRT PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; LMP1 PROTEIN; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; NANOPARTICLE; NUCLEIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER GROWTH; CANCER RISK; CELL CYCLE PROGRESSION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CHEMICAL COMPOSITION; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; EXOCYTOSIS; EXOSOME; EXTRACELLULAR SPACE; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; LIFESTYLE; MASS SPECTROMETRY; MEMBRANE VESICLE; MOLECULAR BIOLOGY; MOLECULAR SIZE; MOUTH SQUAMOUS CELL CARCINOMA; MULTIVESICULAR BODY; NASOPHARYNX CANCER; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SALIVA; TUMOR MICROENVIRONMENT;

ANIMALS; CELL-DERIVED MICROPARTICLES; EXOSOMES; HEAD AND NECK NEOPLASMS; HERPESVIRUS 4, HUMAN; HUMANS; MICRORNAS; PROTEOME; RNA, VIRAL; SALIVA; TUMOR MARKERS, BIOLOGICAL;

HUMAN HERPESVIRUS 4;

EID: 84878656074     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200533     Document Type: Review

References (172)

1. Barry, O. P., Pratico, D., Lawson, J. A., FitzGerald, G. A., Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J. Clin. Invest. 1997, 99, 2118-2127.
2. MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K. et al., Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 2001, 15, 825-835.
3. Grant, R., Ansa-Addo, E., Stratton, D., Antwi-Baffour, S. et al., A filtration-based protocol to isolate human plasma membrane-derived vesicles and exosomes from blood plasma. J. Immunol. Methods 2011, 371, 143-151.
4. Pisitkun, T., Shen, R. F., Knepper, M. A., Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 2004, 101, 13368-13373.
5. Street, J. M., Barran, P. E., Mackay, C. L., Weidt, S. et al., Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J. Transl. Med. 2012, 10, 5.
6. Keller, S., Rupp, C., Stoeck, A., Runz, S. et al., CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int. 2007, 72, 1095-1102.
7. Prado, N., Marazuela, E. G., Segura, E., Fernandez-Garcia, H. et al., Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction. J. Immunol. 2008, 181, 1519-1525.
8. Skriner, K., Adolph, K., Jungblut, P. R., Burmester, G. R., Association of citrullinated proteins with synovial exosomes. Arthritis Rheum. 2006, 54, 3809-3814.
9. Runz, S., Keller, S., Rupp, C., Stoeck, A. et al., Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol. Oncol. 2007, 107, 563-571.
10. Admyre, C., Johansson, S. M., Qazi, K. R., Filen, J. J. et al., Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 2007, 179, 1969-1978.
11. Gonzalez-Begne, M., Lu, B., Han, X., Hagen, F. K. et al., Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J. Proteome Res. 2009, 8, 1304-1314.
12. Ogawa, Y., Kanai-Azuma, M., Akimoto, Y., Kawakami, H., Yanoshita, R., Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Biol. Pharm. Bull. 2008, 31, 1059-1062.
13. Stoorvogel, W., Kleijmeer, M. J., Geuze, H. J., Raposo, G., The biogenesis and functions of exosomes. Traffic 2002, 3, 321-330.
14. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M. et al., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654-659.
15. Pisetsky, D. S., Gauley, J., Ullal, A. J., Microparticles as a source of extracellular DNA. Immunol. Res. 2010, 49, 227-234.
16. Thery, C., Zitvogel, L., Amigorena, S., Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2, 569-579.
17. Subra, C., Grand, D., Laulagnier, K., Stella, A. et al., Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J. Lipid Res. 2010, 51, 2105-2120.
18. Meckes, D. G., Jr., Shair, K. H., Marquitz, A. R., Kung, C. P. et al., Human tumor virus utilizes exosomes for intercellular communication. Proc. Natl. Acad. Sci. U S A 2010, 107, 20370-20375.
19. Wurdinger, T., Gatson, N. N., Balaj, L., Kaur, B. et al., Extracellular vesicles and their convergencewith viral pathways. Adv. Virol. 2012, 767694.
20. Gyorgy, B., Szabo, T. G., Pasztoi, M., Pal, Z. et al., Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol. Life Sci. 2011, 68, 2667-2688.
21. Cocucci, E., Racchetti, G., Meldolesi, J., Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009, 19, 43-51.
22. Gyorgy, B., Modos, K., Pallinger, E., Paloczi, K. et al., Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood 2011, 117, e39-e48.
23. Hristov, M., Erl, W., Linder, S., Weber, P. C., Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood 2004, 104, 2761-2766.
24. Kesimer, M., Scull, M., Brighton, B., DeMaria, G. et al., Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 2009, 23, 1858-1868.
25. Denzer, K., Kleijmeer, M. J., Heijnen, H. F., Stoorvogel, W., Geuze, H. J., Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 2000, 113(Pt 19), 3365-3374.
26. Mathivanan, S., Ji, H., Simpson, R. J., Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 2010, 73, 1907-1920.
27. Baietti, M. F., Zhang, Z., Mortier, E., Melchior, A. et al., Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol. 2012, 14, 677-685.
28. Hurley, J. H., Odorizzi, G., Get on the exosome bus with ALIX. Nat. Cell Biol. 2012, 14, 654-655.
29. Nabhan, J. F., Hu, R., Oh, R. S., Cohen, S. N., Lu, Q., Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc. Natl. Acad. Sci. U S A 2012, 109, 4146-4151.
30. Mathivanan, S., Lim, J. W., Tauro, B. J., Ji, H. et al., Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell Proteomics 2010, 9, 197-208.
31. Thery, C., Ostrowski, M., Segura, E., Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009, 9, 581-593.
32. Kahner, B. N., Dorsam, R. T., Kunapuli, S. P., Role of P2Y receptor subtypes in platelet-derived microparticle generation. Front. Biosci. 2008, 13, 433-439.
33. Pilzer, D., Gasser, O., Moskovich, O., Schifferli, J. A., Fishelson, Z., Emission of membrane vesicles: roles in complement resistance, immunity and cancer. Springer Semin. Immunopathol. 2005, 27, 375-387.
34. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., Ratajczak, M. Z., Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20, 1487-1495.
35. D'Souza-Schorey, C., Clancy, J. W., Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev. 2012, 26, 1287-1299.
36. D'Asti, E., Garnier, D., Lee, T. H., Montermini, L. et al., Oncogenic extracellular vesicles in brain tumor progression. Front. Physiol. 2012, 3, 294.
37. Muralidharan-Chari, V., Clancy, J. W., Sedgwick, A., D'Souza-Schorey, C., Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 2010, 123, 1603-1611.
38. van Kilsdonk, J. W., van Kempen, L. C., van Muijen, G. N., Ruiter, D. J., Swart, G. W., Soluble adhesion molecules in human cancers: sources and fates. Eur. J. Cell Biol. 2010, 89, 415-427.
39. van Doormaal, F. F., Kleinjan, A., Di Nisio, M., Buller, H. R., Nieuwland, R., Cell-derived microvesicles and cancer. Neth. J. Med. 2009, 67, 266-273.
40. Raimondo, F., Morosi, L., Chinello, C., Magni, F., Pitto, M., Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics 2011, 11, 709-720.
41. Rak, J., Guha, A., Extracellular vesicles-vehicles that spread cancer genes. Bioessays 2012, 34, 489-497.
42. Thery, C., Amigorena, S., Raposo, G., Clayton, A., Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 2006, Chapter 3, Unit 3.22.1-3.22.29, doi: 10.1002/0471143030.cb0322s30.
43. Taylor, D. D., Zacharias,W., Gercel-Taylor, C., Exosome isolation for proteomic analyses and RNA profiling. Methods Mol. Biol. 2011, 728, 235-246.
44. Welton, J. L., Khanna, S., Giles, P. J., Brennan, P. et al., Proteomics analysis of bladder cancer exosomes. Mol. Cell Proteomics 2010, 9, 1324-1338.
45. Miranda, K. C., Bond, D. T., McKee, M., Skog, J. et al., Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 2010, 78, 191-199.
46. Vlassov, A. V., Magdaleno, S., Setterquist, R., Conrad, R., Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta 2012, 1820, 940-948.
47. Alvarez, M. L., Khosroheidari, M., Kanchi Ravi, R., DiStefano, J. K., Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012, 82, 1024-1032.
48. Cheruvanky, A., Zhou, H., Pisitkun, T., Kopp, J. B. et al., Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am. J. Physiol. Renal Physiol. 2007, 292, F1657-F1661.
49. Chen, C., Skog, J., Hsu, C. H., Lessard, R. T. et al., Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab. Chip 2010, 10, 505-511.
50. Tauro, B. J., Greening, D. W., Mathias, R. A., Ji, H. et al., Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 2012, 56, 293-304.
51. Koga, K., Matsumoto, K., Akiyoshi, T., Kubo, M. et al., Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res. 2005, 25, 3703-3707.
52. Taylor, D. D., Gercel-Taylor, C., MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 2008, 110, 13-21.
53. Bobrie, A., Colombo, M., Raposo, G., Thery, C., Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 2011, 12, 1659-1668.
54. Sharma, S., Gillespie, B. M., Palanisamy, V., Gimzewski, J. K., Quantitative nanostructural and singlemolecule force spectroscopy biomolecular analysis of human-saliva-derived exosomes. Langmuir 2011, 27, 14394-14400.
55. Lee, Y., El Andaloussi, S., Wood, M. J., Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum. Mol. Genet. 2012, 21, R125-R134.
56. Zhou, H., Cheruvanky, A., Hu, X., Matsumoto, T. et al., Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int. 2008, 74, 613-621.
57. Michael, A., Bajracharya, S. D., Yuen, P. S., Zhou, H. et al., Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 2010, 16, 34-38.
58. Pap, E., Pallinger, E., Falus, A., The role of membrane vesicles in tumorigenesis. Crit. Rev. Oncol. Hematol. 2011, 79, 213-223.
59. Simpson, R. J., Jensen, S. S., Lim, J. W., Proteomic profiling of exosomes: current perspectives. Proteomics 2008, 8, 4083-4099.
60. Luga, V., Zhang, L., Viloria-Petit, A. M., Ogunjimi, A. A. et al., Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration. Cell 2012, 151, 1542-1556.
61. Putz, U., Howitt, J., Doan, A., Goh, C. P. et al., The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci. Signal. 2012, 5, ra70.
62. Mathivanan, S., Simpson, R. J., ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 2009, 9, 4997-5000.
63. Mathivanan, S., Fahner, C. J., Reid, G. E., Simpson, R. J., ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 2012, 40, D1241-D1244.
64. Jemal, A., Siegel, R., Ward, E., Hao, Y. et al., Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59, 225-249.
65. Marur, S., D'Souza, G.,Westra,W. H., Forastiere, A. A., HPVassociated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010, 11, 781-789.
66. Pegtel, D. M., Cosmopoulos, K., Thorley-Lawson, D. A., van Eijndhoven, M. A. et al., Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U S A 2010, 107, 6328-6333.
67. Yu, M. C., Yuan, J. M., Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol. 2002, 12, 421-429.
68. Raab-Traub, N., Epstein-Barr virus and nasopharyngeal carcinoma. Semin. Cancer Biol. 1992, 3, 297-307.
69. Raab-Traub, N., Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 2002, 12, 431-441.
70. Davison, A. J., Eberle, R., Ehlers, B., Hayward, G. S. et al., The order Herpesvirales. Arch. Virol. 2009, 154, 171-177.
71. Bornkamm, G.W., Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Int. J. Cancer 2009, 124, 1745-1755.
72. Delecluse, H. J., Feederle, R., O'Sullivan, B., Taniere, P., Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J. Clin. Pathol. 2007, 60, 1358-1364.
73. Epstein, M. A., Achong, B. G., Barr, Y. M., Virus particles in cultured lymphoblasts from Burkitt's Lymphoma. Lancet 1964, 1, 702-703.
74. Lim, W. H., Russ, G. R., Coates, P. T., Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Nephrology (Carlton) 2006, 11, 355-366.
75. Gourzones, C., Gelin, A., Bombik, I., Klibi, J. et al., Extracellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol J. 2010, 7, 271.
76. Gourzones, C., Barjon, C., Busson, P., Host-tumor interactions in nasopharyngeal carcinomas. Semin. Cancer Biol. 2012, 22, 127-136.
77. Klibi, J., Niki, T., Riedel, A., Pioche-Durieu, C. et al., Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virusinfected nasopharyngeal carcinoma cells. Blood 2009, 113, 1957-1966.
78. Houali, K.,Wang, X., Shimizu, Y., Djennaoui, D. et al., A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 2007, 13, 4993-5000.
79. Keryer-Bibens, C., Pioche-Durieu, C., Villemant, C., Souquere, S. et al., Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer 2006, 6, 283.
80. Zhu, C., Anderson, A. C., Schubart, A., Xiong, H. et al., The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 2005, 6, 1245-1252.
81. Morris, M. A., Dawson, C. W., Young, L. S., Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol. 2009, 5, 811-825.
82. Wang, D., Liebowitz, D., Kieff, E., An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985, 43, 831-840.
83. Dukers, D. F., Meij, P., Vervoort, M. B., Vos, W. et al., Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J. Immunol. 2000, 165, 663-670.
84. Flanagan, J., Middeldorp, J., Sculley, T., Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J. Gen. Virol. 2003, 84, 1871-1879.
85. Cameron, J. E., Yin, Q., Fewell, C., Lacey, M. et al., Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J. Virol. 2008, 82, 1946-1958.
86. Esquela-Kerscher, A., Slack, F. J., Oncomirs -microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6, 259-269.
87. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P., Burge, C. B., Prediction of mammalian microRNA targets. Cell 2003, 115, 787-798.
88. Chen, K., Rajewsky, N., The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet. 2007, 8, 93-103.
89. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K. et al., MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133, 647-658.
90. Chan, J. A., Krichevsky, A. M., Kosik, K. S., MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65, 6029-6033.
91. Si, M. L., Zhu, S., Wu, H., Lu, Z. et al., miR-21-mediated tumor growth. Oncogene 2007, 26, 2799-2803.
92. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E. et al., MicroRNA expression profiles classify human cancers. Nature 2005, 435, 834-838.
93. Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S. et al., Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64, 3753-3756.
94. Yanaihara, N., Caplen, N., Bowman, E., Seike, M. et al., Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9, 189-198.
95. Corney, D. C., Nikitin, A. Y., MicroRNA and ovarian cancer. Histol. Histopathol. 2008, 23, 1161-1169.
96. Duchaine, T. F., Slack, F. J., RNA interference and micro RNAoriented therapy in cancer: rationales, promises, and challenges. Curr. Oncol. 2009, 16, 61-66.
97. Pfeffer, S., Zavolan, M., Grasser, F. A., Chien, M. et al., Identification of virus-encoded microRNAs. Science 2004, 304, 734-736.
98. Edwards, R. H., Marquitz, A. R., Raab-Traub, N., Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J. Virol. 2008, 82, 9094-9106.
99. Cai, X., Schafer, A., Lu, S., Bilello, J. P. et al., Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006, 2, e23.
100. Cosmopoulos, K., Pegtel, M., Hawkins, J., Moffett, H. et al., Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J. Virol. 2009, 83, 2357-2367.
101. Pratt, Z. L., Kuzembayeva, M., Sengupta, S., Sugden, B., The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 2009, 386, 387-397.
102. Xia, T., O'Hara, A., Araujo, I., Barreto, J. et al., EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 2008, 68, 1436-1442.
103. Chen, S. J., Chen, G. H., Chen, Y. H., Liu, C. Y. et al., Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One 2010, 5, e12745.
104. Grundhoff, A., Sullivan, C. S., Ganem, D., A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006, 12, 733-750.
105. Zhu, J. Y., Pfuhl, T., Motsch, N., Barth, S. et al., Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J. Virol. 2009, 83, 3333-3341.
106. Marquitz, A. R., Mathur, A., Shair, K. H., Raab-Traub, N., Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression. Proc. Natl. Acad. Sci. U S A 2012, 109, 9593-9598.
107. Raab-Traub, N., Novel mechanisms of EBV-induced oncogenesis. Curr. Opin. Virol. 2012, 2, 453-458.
108. Barth, S., Pfuhl, T., Mamiani, A., Ehses, C. et al., Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res. 2008, 36, 666-675.
109. Wong, A. M., Kong, K. L., Tsang, J. W., Kwong, D. L., Guan, X. Y., Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 2011, 118, 698-710.
110. Choy, E. Y., Siu, K. L., Kok, K. H., Lung, R. W. et al., An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J. Exp. Med. 2008, 205, 2551-2560.
111. Nachmani, D., Stern-Ginossar, N., Sarid, R., Mandelboim, O., Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 2009, 5, 376-385.
112. Gandhi, M. K., Moll, G., Smith, C., Dua, U. et al., Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma. Blood 2007, 110, 1326-1329.
113. Lung, R. W., Tong, J. H., Sung, Y. M., Leung, P. S. et al., Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 2009, 11, 1174-1184.
114. Bergmann, C., Strauss, L., Wieckowski, E., Czystowska, M. et al., Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression. Head Neck 2009, 31, 371-380.
115. Kim, J. W., Wieckowski, E., Taylor, D. D., Reichert, T. E. et al., Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin. Cancer Res. 2005, 11, 1010-1020.
116. Yang, C., Robbins, P. D., The roles of tumor-derived exosomes in cancer pathogenesis. Clin. Dev. Immunol. 2011, 2011, 842-849.
117. Zheng, S. Y., Li, D. C., Zhang, Z. D., Zhao, J., Ge, J. F., Adenovirus-mediated FasL gene transfer into human gastric carcinoma. World J.Gastroenterol. 2005, 11, 3446-3450.
118. Li, X., Liu, Y. H., Zhang, Y. P., Zhang, S. et al., Fas ligand delivery by a prostate-restricted replicative adenovirus enhances safety and antitumor efficacy. Clin. Cancer Res. 2007, 13, 5463-5473.
119. Ambar, B. B., Frei, K., Malipiero, U., Morelli, A. E. et al., Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand. Hum. Gene Ther. 1999, 10, 1641-1648.
120. Das, S. N., Khare, P., Singh, M. K., Sharma, S. C., Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma. Indian J. Med. Res. 2011, 134, 54-60.
121. Ji, X., Jiang, C., Liu, Y., Bu, D., Xiao, S., Fas ligand gene transfer effectively induces apoptosis in head and neck cancer cells. Acta Otolaryngol. 2011, 131, 876-881.
122. Forastiere, A., Koch, W., Trotti, A., Sidransky, D., Head and neck cancer. N. Engl. J. Med. 2001, 345, 1890-1900.
123. Soini, H. A., Klouckova, I., Wiesler, D., Oberzaucher, E. et al., Analysis of volatile organic compounds in human saliva by a static sorptive extraction method and gas chromatography-mass spectrometry. J. Chem. Ecol. 2010, 36, 1035-1042.
124. Lamy, E., Mau, M., Saliva proteomics as an emerging, noninvasive tool to study livestock physiology, nutrition and diseases. J. Proteomics 2012, 75, 4251-4258.
125. Chiappin, S., Antonelli, G., Gatti, R., De Palo, E. F., Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin. Chim. Acta 2007, 383, 30-40.
126. Liu, J., Duan, Y., Saliva: a potential media for disease diagnostics and monitoring. Oral Oncol. 2012, 48, 569-577.
127. Ohshiro, K., Rosenthal, D. I., Koomen, J. M., Streckfus, C. F. et al., Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. Int. J. Oncol. 2007, 30, 743-749.
128. Lee, J. M., Garon, E., Wong, D. T., Salivary diagnostics. Orthod. Craniofac. Res. 2009, 12, 206-211.
129. Yan, W., Apweiler, R., Balgley, B. M., Boontheung, P. et al., Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin. Appl. 2009, 3, 116-134.
130. Drake, R. R., Cazare, L. H., Semmes, O. J., Wadsworth, J. T., Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers. Expert Rev. Mol. Diagn. 2005, 5, 93-100.
131. Yeh, C. K., Christodoulides, N. J., Floriano, P. N., Miller, C. S. et al., Current development of saliva/oral fluid-based diagnostics. Tex Dent. J. 2010, 127, 651-661.
132. Henson, B. S., Wong, D. T., Collection, storage, and processing of saliva samples for downstream molecular applications. Methods Mol. Biol. 2010, 666, 21-30.
133. Streckfus, C. F., Dubinsky, W. P., Proteomic analysis of saliva for cancer diagnosis. Expert Rev. Proteomics 2007, 4, 329-332.
134. Bigler, L. R., Streckfus, C. F., Dubinsky, W. P., Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity. Clin. Lab. Med. 2009, 29, 71-85.
135. Streckfus, C., Bigler, L., The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study. Adv. Dent. Res. 2005, 18, 17-24.
136. Wu, Z. Z., Wang, J. G., Zhang, X. L., Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J. Gastroenterol. 2009, 15, 865-870.
137. Amado, F. M., Ferreira, R. P., Vitorino, R., One decade of salivary proteomics: current approaches and outstanding challenges. Clin. Biochem. 2013, 46, 506-517.
138. Pickering, V., Jordan, R. C., Schmidt, B. L., Elevated salivary endothelin levels in oral cancer patients-a pilot study. Oral Oncol. 2007, 43, 37-41.
139. Dowling, P.,Wormald, R., Meleady, P., Henry,M. et al., Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J. Proteomics 2008, 71, 168-175.
140. Alam, H., Bhate, A. V., Gangadaran, P., Sawant, S. S. et al., Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma. BMC Cancer 2012, 12, 32.
141. Bankfalvi, A., Krassort, M., Buchwalow, I. B., Vegh, A. et al., Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. J. Pathol. 2002, 198, 343-351.
142. Piao, S., Liu, Y., Hu, J., Guo, F. et al., USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma. PLoS One 2012, 7, e42540.
143. Franzmann, E. J., Reategui, E. P., Carraway, K. L., Hamilton, K. L. et al., Salivary soluble CD44: a potential molecular marker for head and neck cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 735-739.
144. Franzmann, E. J., Reategui, E. P., Pedroso, F., Pernas, F. G. et al., Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1348-1355.
145. Franzmann, E. J., Reategui, E. P., Pereira, L. H., Pedroso, F. et al., Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma. Head Neck 2012, 34, 687-695.
146. Nagler, R., Bahar, G., Shpitzer, T., Feinmesser, R., Concomitant analysis of salivary tumor markers-a new diagnostic tool for oral cancer. Clin. Cancer Res. 2006, 12, 3979-3984.
147. Kurokawa, H., Yamashita, Y., Tokudome, S., Kajiyama, M., Combination assay for tumor markers in oral squamous cell carcinoma. J. Oral Maxillofac. Surg. 1997, 55, 964-966.
148. Warnakulasuriya, S., Soussi, T., Maher, R., Johnson, N., Tavassoli, M., Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J. Pathol. 2000, 192, 52-57.
149. Lee, Y. H.,Wong, D. T., Saliva: an emerging biofluid for early detection of diseases. Am. J. Dent. 2009, 22, 241-248.
150. Deutsch,O., Fleissig, Y., Zaks, B., Krief, G. et al., An approach to remove alpha amylase for proteomic analysis of low abundance biomarkers in human saliva. Electrophoresis 2008, 29, 4150-4157.
151. Amado, F., Lobo, M. J., Domingues, P., Duarte, J. A., Vitorino, R., Salivary peptidomics. Expert Rev. Proteomics 2010, 7, 709-721.
152. Nakamura, H., Kawakami, A., Izumi, M.,Nakashima, T. et al., Detection of the soluble form of Fas ligand (sFasL) and sFas in the saliva from patients with Sjogren's syndrome. Clin. Exp. Rheumatol. 2005, 23, 915.
153. Skog, J., Wurdinger, T., van Rijn, S., Meijer, D. H. et al., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10, 1470-1476.
154. Elashoff, D., Zhou, H., Reiss, J.,Wang, J. et al., Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol. Biomarkers Prev. 2012, 21, 664-672.
155. Lasser, C., Alikhani, V. S., Ekstrom, K., Eldh, M. et al., Human saliva, plasma and breastmilk exosomes contain RNA: uptake by macrophages. J. Transl. Med. 2011, 9, 9.
156. Al-Tarawneh, S. K., Border, M. B., Dibble, C. F., Bencharit, S., Defining salivary biomarkers using mass spectrometrybased proteomics: a systematic review. OMICS 2011, 15, 353-361.
157. Sharma, S., Rasool, H. I., Palanisamy, V., Mathisen, C. et al., Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano 2010, 4, 1921-1926.
158. Palanisamy, V., Sharma, S., Deshpande, A., Zhou, H. et al., Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS One 2010, 5, e8577.
159. Ogawa, Y., Miura, Y., Harazono, A., Kanai-Azuma, M. et al., Proteomic analysis of two types of exosomes in human whole saliva. Biol. Pharm. Bull. 2011, 34, 13-23.
160. Denny, P., Hagen, F. K., Hardt, M., Liao, L. et al., The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J. Proteome Res. 2008, 7, 1994-2006.
161. Hirtz, C., Chevalier, F., Centeno, D., Egea, J. C. et al., Complexity of the human whole saliva proteome. J. Physiol. Biochem. 2005, 61, 469-480.
162. de Jong, E. P., Xie, H., Onsongo, G., Stone,M. D. et al., Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant andmalignant oral lesions. PLoS One 2010, 5, e11148.
163. Poliakov, A., Spilman, M., Dokland, T., Amling, C. L., Mobley, J. A., Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate 2009, 69, 159-167.
164. Deregibus, M. C., Cantaluppi, V., Calogero, R., Lo Iacono, M. et al., Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007, 110, 2440-2448.
165. Xiao, H., Wong, D. T., Proteomic analysis of microvesicles in human saliva by gel electrophoresis with liquid chromatography-mass spectrometry. Anal. Chim. Acta 2012, 723, 61-67.
166. Pioche-Durieu, C., Keryer, C., Souquere, S., Bosq, J. et al., In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin. J. Virol. 2005, 79, 13326-13337.
167. Marleau, A. M., Chen, C. S., Joyce, J. A., Tullis, R. H., Exosome removal as a therapeutic adjuvant in cancer. J. Transl. Med. 2012, 10, 134.
168. Dolken, L., Malterer, G., Erhard, F., Kothe, S. et al., Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 2010, 7, 324-334.
169. Marquitz, A. R., Mathur, A., Nam, C. S., Raab-Traub, N., The Epstein-Barr Virus BART microRNAs target the proapoptotic protein Bim. Virology 2011, 412, 392-400.
170. Petrocca, F., Visone, R., Onelli, M. R., Shah,M. H. et al., E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008, 13, 272-286.
171. Iizasa, H., Wulff, B. E., Alla, N. R., Maragkakis, M. et al., Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J. Biol. Chem. 2010, 285, 33358-33370.
172. Lo, A. K., To, K. F., Lo, K. W., Lung, R. W. et al., Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc. Natl. Acad. Sci. U S A 2007, 104, 16164-16169.